Skip to main content
SpringerLink
Log in

Dermatitis herpetiformis: Effects of sulfones and sulfonamides on neutrophil myeloperoxidase-mediated iodination and cytotoxicity

  • Original Articles
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

The effects of sulfones and sulfonamides on neutrophil myeloperoxidase-mediated iodination and cytotoxicity were studied usingin vitro assays to measure these parameters. Leukocyte iodination was documented using a quantitative assay to measure the iodination of protein by human neutrophils undergoing phagocytosis. Cytotoxicity for the tumor cell line LSTRA by human neutrophils activated by exposure to phorbol myristate acetate was measured by a51Cr release assay. Dapsone, diasone, and sulfapyridine, at concentrations comparable to serum levels obtained by therapeutic doses of drug, effectively inhibited iodination and cytotoxicity mediated by human neutrophils. Other sulfonamides showed little inhibition of either iodination or cytotoxicity. The amount of inhibition was comparable to that seen with the inhibitors azide or cyanide and occurred in a dose dependent manner with all three drugs. A cell-free cytotoxic system using myeloperoxidase, iodide, a H2O2 generating system, and target cells also showed inhibition by dapsone, diasone and sulfapyridine in a similar fashion. The active drugs inhibited both the intra- and the extracellular myeloperoxidase-H2O2-halide cytotoxic systems. Serial iodination studies of four dermatitis herpetiformis patients, evaluated while taking dapsone or sulfapyridine, showed inhibition of iodination by either drug. Levels of IgA immune complexes, as measured by the Raji cell radioimmune assay adapted for IgA, did not change when medication was withheld. These studies demonstrate that dapsone, diasone, and sulfapyridine inhibit both neutrophil iodination and cytotoxicity for tumor cells, while other sulfonamides have no effect. This confirms previous studies showing inhibition by myeloperoxidase mediated iodination by dapsone. Furthermore, the effect on neutrophils is quickly reversible;in vivo administered drug has no effect onin vitro function. The active drugs inhibit both intra- and extracellular cytotoxic systems. This may represent an important mechanism by which these drugs produce their therapeutic effects when used to treat inflammatory skin diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Alexander JOD: Dermatitis Herpetiformis. Philadelphia, W. B. Saunders, 1975

    Google Scholar 

  2. MacVicar DN, Graham JH, Burgoon CF: Dermatitis herpetiformis, erythema multiforme and bullous pemphigoid: A histological and histochemical study. J Invest Dermatol 41:289–300, 1963

    Google Scholar 

  3. VanderMeer JF: Granular deposits of immunoglobulins in the skin of patients with dermatitis herpetiformis: An immunofluorescent study. Br J Dermatol 81:493–503, 1969

    Google Scholar 

  4. Zone JJ, La Salle BA, Provost TT: Circulating immune complexes of IgA type in dermatitis herpetiformis. J Invest Dermatol 75:152–155, 1980

    Google Scholar 

  5. Hall RP, Lawley TJ, Heck JA, Katz SI: IgA-containing circulating immune complexes in dermatitis herpetiformis, Henoch-Schonlein purpura, systemic lupus erythematosus, and other diseases. Clin Exp Immunol 40:431–437, 1980

    Google Scholar 

  6. Lang PB: Sulfones and sulfonamides in dermatology today. J Am Acad Dermatol 1:479–492, 1979

    Google Scholar 

  7. Weinstein L: The sulfonamides.In The Pharmacological Basis of Therapeutics, 4th ed, LS Goodman, A Gilman (eds). New York, Macmillan, 1970, pp 1181–1185

    Google Scholar 

  8. Stendahl O, Molin L, Dahlgren C: The inhibition of polymorphonuclear leukocyte cytotoxicity by dapsone. A possible mechanism in the treatment of dermatitis herpetiformis. J Clin Invest 62:214–220, 1978

    Google Scholar 

  9. Repine JE, White JG, Clawson CC, Holmes BM: Effects of phorbol myristate acetate on the metabolism and ultrastructure of neutrophils in chronic granulomatous disease. J Clin Invest 54:83–90, 1974

    Google Scholar 

  10. Repine JE, White JG, Clawson CC, Holmes BM: The influence of phorbol myristate acetate on oxygen consumption by polymorphonuclear leukocytes. J Lab Clin Med 83:911–920, 1974

    Google Scholar 

  11. Goldstein IM, Hoffstein ST, Weissman G: Mechanisms of lysosomal enzyme release from human polymorphonuclear leukocytes. Effects of phorbol myristate acetate. J Cell Biol 66:647–652, 1975

    Google Scholar 

  12. DeChatelet LR, Shirley PS, Johnson RB Jr: Effect of phorbol myristate acetate on the oxidative metabolism of human polymorphonuclear leukocytes. Blood 47:545–554, 1976

    Google Scholar 

  13. Bentwood BJ, Henson PM: The sequential release of granule constituents from human neutrophils. J Immunol 124:855–862, 1980

    Google Scholar 

  14. Theofilopoulos AN, Wilson CB, Dixon FJ: The Raji cell radioimmune assay for detecting immune complexes in human sera. J Clin Invest 57:169–182, 1976

    Google Scholar 

  15. McConahey PJ, Dixon FJ: A method of trace iodination of proteins for immunologic studies. Int Arch Allergy Appl Immunol 29:185–189, 1966

    Google Scholar 

  16. Ishizaka K, Ishizaka I, Salmon S, Fudenberg H: Biologic activities of aggregated gamma globulin VIII. Aggregated immuno-globulins of different classes. J Immunol 9:82–91, 1967

    Google Scholar 

  17. Boyum A: Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 21 (Suppl 97):77–89, 1968

    Google Scholar 

  18. Grant JA, Dupree E, Thueson DO: Complement-mediated release of histamine from human basophils. III. Possible regulatory role of microtubules and microfilaments. J Allergy Clin Immunol 60:306–311, 1977

    Google Scholar 

  19. Clark RA, Klebanoff SJ, Einstein AB, Fefer A: Peroxidase-H2O2-halide system: cytotoxic effect on mammalian tumor cells. Blood 45:161–170, 1975

    Google Scholar 

  20. Clark RA, Szot S: The myeloperoxidase-hydrogen peroxidehalide system as effector of neutrophil-mediated tumor cell cytotoxicity. J Immunol 126:1295–1301, 1981

    Google Scholar 

  21. Olsson I, Olofsson T, Odeberg H: Myeloperoxidase-mediated iodination in granulocytes. Scan J Haematol 9:483–491, 1972

    Google Scholar 

  22. Worthington Enzyme Manual. Freeshold, NJ, Worthington, 1972, p 43

  23. Pichaver AH, Ratcliffe NA, Williams AE, Smith H: Cytotoxic effects of peritoneal neutrophils on a syngeneic rat tumour. Nature (New Biol) 235:186–187, 1972

    Google Scholar 

  24. Clark RA, Klebanoff SJ: Neutrophil-mediated tumor cell cytotoxicity: Role of the peroxidase system. J Exp Med 141:1442–1447, 1975

    Google Scholar 

  25. Clark RA, Klebanoff SJ: Studies on the mechanism of antibody-dependent polymorphonuclear leukocyte mediated cytotoxicity. J Immunol 119:1413–1418, 1977

    Google Scholar 

  26. Nathan CF, Brukner LH, Silverstein SC, Cohn AZ: Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide. J Exp Med 149:84–99, 1979

    Google Scholar 

  27. Nathan CF, Silverstein SC, Brukner LH, Cohn ZA: Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity. J Exp Med 149:100–113, 1979

    Google Scholar 

  28. Slikva A, LoBuglio AF, Weiss SJ: A potential role for hypochlorous acid in granulocyte-mediated tumor cell cytotoxicity. Blood 55:347–350, 1980

    Google Scholar 

  29. Weiss SJ, LoBuglio AF: An oxygen-dependent mechanism of neutrophil-mediated cytotoxicity. Blood 55:1020–1024, 1980

    Google Scholar 

  30. Klebanoff SJ: Antimicrobial mechanisms in neutrophilic polymorphonuclear leukocytes. Semin Hematol 12:117–142, 1975

    Google Scholar 

  31. Babior BM: Oxygen-dependent microbial killing by phagocytes. N Engl J Med 298:721–725, 1978

    Google Scholar 

  32. Weiss SJ, Slivka A: Monocyte and granulocyte-mediated tumor cell destruction. A role for the hydrogen peroxide-myeloperoxidase-chloride system. J Clin Invest 69:255–262, 1982

    Google Scholar 

  33. Agner K: Biological effects of hypochlorous acid formed by “MPO”-peroxidation in the presence of chloride ions.In Structures and Function of Oxidation-Reduction Enzymes, A Akeson, A Ehrenberg (eds). Oxford, Pergamon Press, 1972, pp 329–335

    Google Scholar 

  34. Thomas EL: Myeloperoxidase, hydrogen peroxide, chloride antimicrobial system: Nitrogen-chlorine derivatives of bacterial components in bactericidal action againstEscherichia coli. Infect Immun 23:522–531, 1979

    Google Scholar 

  35. Thomas EL: Myeloperoxidase-hydrogen peroxide-chloride anti-microbial system: Effect of exogenous amines on antibacterial action againstEscherichia coli. Infect Immun 25:110–116, 1979

    Google Scholar 

  36. Lehrer RI: Inhibition by sulfonamides of the candidacidal activity of human neutrophils. J Clin Invest 50:2498–2502, 1971

    Google Scholar 

  37. Stendahl O, Molin L, Dahlgren C: The inhibition of polymorphonuclear leukocyte cytotoxicity by dapsone. A possible mechanism in the treatment of dermatitis herpetiformis. J Clin Invest 62:214–220, 1978

    Google Scholar 

  38. Thompson DM, Souhami R: Suppression of the Arthus reaction in the guinea pig by dapsone. Proc R Soc Med 68:273–276, 1975

    Google Scholar 

  39. Beiguelman B, Pisani RCB: Effect of DDS on phyto-hemagglutinin-induced lymphocyte transformation. Int J Lepr 42:412–414, 1974

    Google Scholar 

  40. Barranco VP: Inhibition of lysosomal enzymes by dapsone. Arch Dermatol 110:563–566, 1974

    Google Scholar 

  41. Seah PP, Maazaheri MR, Fry L: Complement in the skin of patients with dermatitis herpetiformis. Br J Dermatol 89 (Suppl):12, 1973

    Google Scholar 

  42. Millikan LE, Conway FR: Effect of drugs on the Pillemer pthway—dapsone. J Invest Dermatol 62:541, 1974

    Google Scholar 

  43. Katz SI, Hertz KC, Crawford PS, Frank MM, Lawley TJ: Effect of sulfones on complement deposition in dermatitis herpetiformis and on complement mediated guinea pig reactions. J Invest Dermatol 67:688–690, 1976

    Google Scholar 

  44. Seah PP, Fry L: Immunoglobulins in the skin in dermatitis herpetiformis and their relevance in diagnosis. Br J Dermatol 92:154–166, 1975

    Google Scholar 

  45. Weissmann G, Smolen JE, Karchak HM: Release of inflammatory mediators from stimulated neutrophils. N Engl J Med 303:27–34, 1980

    Google Scholar 

  46. Douglas WS, Alexander J: Dermatitis herpetiformis, iodine compounds and thyrotoxicosis. Br J Dermatol 92:596–598, 1975

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, The Oregon Health Sciences University, 97201, Portland, Oregon

    John A. Kazmierowski, John E. Ross, David S. Peizner & Kirk D. Wuepper

Authors
  1. John A. Kazmierowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John E. Ross
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David S. Peizner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kirk D. Wuepper
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kazmierowski, J.A., Ross, J.E., Peizner, D.S. et al. Dermatitis herpetiformis: Effects of sulfones and sulfonamides on neutrophil myeloperoxidase-mediated iodination and cytotoxicity. J Clin Immunol 4, 55–64 (1984). https://doi.org/10.1007/BF00915288

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00915288

Key words

Search

Navigation